Rheumatoid Arthritis (RA) Prevention: Clinical Trials

3 trials for Rheumatoid Arthritis (RA) Prevention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting, 1 terminated. 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 1, Recruiting 1
Phase 21Terminated 1

Follow this condition Literature Review of Rheumatoid Arthritis (RA) Prevention trials Research Report on Rheumatoid Arthritis (RA) Prevention

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Development and Evaluation of the Effectiveness of the SMART-HAND Protocol for Hand Rehabilitation in Patients With Rheumatoid Arthritis
SMART-HAND Protocol, Conventional Hand Rehabilitation, Joint Protection and Ergonomic Education - Rheumatoid Arthritis, Rheumatoid Arthritis (RA
Not applicableNot yet recruitingIstanbul University - Cerrahpasa1322026-10-012026-08-14
Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.
Resveratrol 1 gm., Methotrexate - Rheumatic Arthritis, Rheumatoid Arthritis (RA) Prevention
Not applicableRecruitingAin Shams University1182025-08-012025-07-28
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Hydroxychloroquine, HCQ Placebo - Healthy Participants, Rheumatoid Arthritis (RA) Prevention
Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)1442016-04-272025-06-12

Narrower conditions

Arthritis, Rheumatoid (3)  ·  Rheumatic Fever (1)

Broader conditions

Arthritis (3)  ·  Autoimmune Diseases (3)  ·  Connective Tissue Diseases (3)  ·  Immune System Diseases (3)  ·  Joint Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Rheumatic Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Streptococcal Infections (1)

Interventions

Hydroxychloroquine (1)  ·  Methotrexate (1)

Sponsors

Ain Shams University (1)  ·  Istanbul University - Cerrahpasa (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

Egypt (1)  ·  United States (1)

Top investigators

Al Shymaa Farouk, Lecturer of Internal Medicine (1)  ·  Christopher Striebich, MD, PhD (1)  ·  Kevin Deane, MD, PhD (1)  ·  Lamia El-Wakeel, Professor of Clinical Pharmacy (1)  ·  Michael Holers, MD (1)  ·  Rana El-Dash, Assistant Lecturer (1)  ·  Sarah Zaki, Professor of Clinical Pharmacy (1)

Results publications

PMID 10888704, PMID 14527120, PMID 14622683, PMID 15862365, PMID 16558670, PMID 18796752, PMID 19258150, PMID 19703734, PMID 20825126, PMID 21295925, PMID 25703454, PMID 25712470, PMID 29194364, PMID 29611086, PMID 31883358, PMID 36369238, PMID 36675041, PMID 37108584, PMID 38827650, PMID 39061843, PMID 40884017, PMID 8823687